<?xml version='1.0' encoding='UTF-8'?>
<search_results><query id="7236">lomustine</query><engine status="OK" timestamp="2014-04-25 09:30:54" name="SpringerLink" id="FW14-e013"/><snippets><snippet id="FW14-e013-7236-01"><link cache="FW14-topics-docs/e013/7236_01.html" timestamp="2014-04-25 09:30:55">http://link.springer.com/article/10.2165/00128415-201214250-00084</link><title>Lomustine</title><description>Reactions Weekly (2012)</description></snippet><snippet id="FW14-e013-7236-02"><link cache="FW14-topics-docs/e013/7236_02.html" timestamp="2014-04-25 09:31:23">http://link.springer.com/article/10.1007/BF03268666</link><title>Lomustine</title><description>Reactions (1987)</description></snippet><snippet id="FW14-e013-7236-03"><link cache="FW14-topics-docs/e013/7236_03.html" timestamp="2014-04-25 09:32:01">http://link.springer.com/article/10.1007/BF03264751</link><title>Lomustine*</title><description>Reactions (1983)</description></snippet><snippet id="FW14-e013-7236-04"><link cache="FW14-topics-docs/e013/7236_04.html" timestamp="2014-04-25 09:32:54">http://link.springer.com/article/10.2165/00128415-199405260-00021</link><title>Lomustine</title><description>Reactions Weekly (1994)</description></snippet><snippet id="FW14-e013-7236-05"><link cache="FW14-topics-docs/e013/7236_05.html" timestamp="2014-04-25 09:33:43">http://link.springer.com/article/10.1007/BF03302442</link><title>HAEMATOPOIETIC INTERACTION SEEN BETWEEN THEOPHYLLINE AND LOMUSTINE</title><description>InPharma (1979)</description></snippet><snippet id="FW14-e013-7236-06"><link cache="FW14-topics-docs/e013/7236_06.html" timestamp="2014-04-25 09:34:22">http://link.springer.com/article/10.1007/BF03312317</link><title>LOMUSTINE SUPERIOR TO CARMUSTINE IN ADVANCED HODGKIN’S DISEASE</title><description>InPharma (1981)</description></snippet><snippet id="FW14-e013-7236-07"><link cache="FW14-topics-docs/e013/7236_07.html" timestamp="2014-04-25 09:34:53">http://link.springer.com/article/10.2165/00128413-200615570-00053</link><title>Lomustine plus temozolomide effective against glioblastoma</title><description>Inpharma Weekly (2006)</description></snippet><snippet id="FW14-e013-7236-08"><link cache="FW14-topics-docs/e013/7236_08.html" timestamp="2014-04-25 09:35:33">http://link.springer.com/article/10.1007/BF03289463</link><title>HOPE FOR REFRACTORY HODGKIN’S DISEASE: DOXORUBICIN AND LOMUSTINE</title><description>InPharma (1977)</description></snippet><snippet id="FW14-e013-7236-09"><link cache="FW14-topics-docs/e013/7236_09.html" timestamp="2014-04-25 09:36:07">http://link.springer.com/article/10.1007/s13318-011-0030-4</link><title>HPLC method validation for the quantification of lomustine to study pharmacokinetics of thermosensitive liposome-encapsulated lomustine containing iohexol for CT imaging in C6 glioma rats</title><description>Luning Zhuang, Jing Gao, Yong Zeng, Fei Yu… in European Journal of Drug Metabolism and Ph… (2011)</description></snippet><snippet id="FW14-e013-7236-10"><link cache="FW14-topics-docs/e013/7236_10.html" timestamp="2014-04-25 09:36:44">http://link.springer.com/article/10.2165/00128413-200112990-00037</link><title>Bleomycin, methotrexate and lomustine may have a palliative role in advanced or recurrent vulval cancer</title><description>Inpharma Weekly (2001)</description></snippet></snippets></search_results>